Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07693751
What this trial is testing

Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer (Locally Advanced or Metastatic)
SOTIO Biotech a.s. 100
Testing effectiveness (Phase 2)Study completedNCT03985046
What this trial is testing

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 75
Testing effectiveness (Phase 2)UnknownNCT05469061
What this trial is testing

Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Carcinoma
The First Affiliated Hospital with Nanjing Medical University 17
Testing effectiveness (Phase 2)Study completedNCT00303927
What this trial is testing

Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 65
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Not applicableStudy completedNCT06024356
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Colorectal Neoplasms
Beijing Friendship Hospital 47
Early research (Phase 1)Study completedNCT00980239
What this trial is testing

HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Who this might be right for
Liver CancerAdvanced Cancer
M.D. Anderson Cancer Center 115
Not applicableStudy completedNCT05534841
What this trial is testing

Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
Centre Hospitalier Universitaire de Nīmes 99
Testing effectiveness (Phase 2)UnknownNCT03146637
What this trial is testing

Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

Who this might be right for
Advanced Liver Cancer
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. 80
Early research (Phase 1)Looking for participantsNCT07417488
What this trial is testing

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

Who this might be right for
Colorectal CancerSmall Bowel Adenocarcinoma
Thomas Jefferson University 18
Early research (Phase 1)Ended earlyNCT05194072
What this trial is testing

Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms+8 more
Seagen, a wholly owned subsidiary of Pfizer 250
Early research (Phase 1)Not Yet RecruitingNCT07608627
What this trial is testing

64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more
City of Hope Medical Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT05450029
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Yanhong Deng 51
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Testing effectiveness (Phase 2)UnknownNCT02527824
What this trial is testing

Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasm
Hallym University Medical Center 31
Early research (Phase 1)Not Yet RecruitingNCT07252661
What this trial is testing

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaThyroid Carcinoma, Medullary+6 more
AccSalus Biosciences, Inc. 40
Testing effectiveness (Phase 2)WithdrawnNCT01178151
What this trial is testing

Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome

Who this might be right for
Peutz-Jeghers SyndromeNeoplastic ProcessesNeoplasm Metastasis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Testing effectiveness (Phase 2)Looking for participantsNCT06603402
What this trial is testing

Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Immunotherapy
Sichuan University 41
Testing effectiveness (Phase 2)UnknownNCT05948449
What this trial is testing

To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Gastric Cancer
Sichuan University 37
Early research (Phase 1)Active Not RecruitingNCT05948826
What this trial is testing

First in Human Study of TORL-3-600 in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumorColorectal Cancer
TORL Biotherapeutics, LLC 70
Next Page